Redefining the therapeutic goals in chronic lymphocytic leukemia: towards an evidence-based, risk-adapted therapy

Ann Oncol. 1999 May;10(5):505-9. doi: 10.1023/a:1026481430446.
No abstract available

Publication types

  • Review

MeSH terms

  • Bacterial Infections / prevention & control
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell / etiology
  • Leukemia, Lymphocytic, Chronic, B-Cell / therapy*
  • Prognosis
  • Vidarabine / analogs & derivatives
  • Vidarabine / therapeutic use

Substances

  • Vidarabine
  • fludarabine